These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 12937125)

  • 21. Stress-induced activation of c-Jun N-terminal kinase in sensory ganglion neurons: accumulation in nuclear domains enriched in splicing factors and distribution in perichromatin fibrils.
    Pena E; Berciano MT; Fernandez R; Crespo P; Lafarga M
    Exp Cell Res; 2000 Apr; 256(1):179-91. PubMed ID: 10739665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinoic acid inhibits hepatic Jun N-terminal kinase-dependent signaling pathway in ethanol-fed rats.
    Chung J; Chavez PR; Russell RM; Wang XD
    Oncogene; 2002 Feb; 21(10):1539-47. PubMed ID: 11896582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases.
    Sprowles A; Robinson D; Wu YM; Kung HJ; Wisdom R
    Exp Cell Res; 2005 Aug; 308(2):459-68. PubMed ID: 15950217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
    Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
    Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation.
    Xiong Y; Jing XP; Zhou XW; Wang XL; Yang Y; Sun XY; Qiu M; Cao FY; Lu YM; Liu R; Wang JZ
    Neurobiol Aging; 2013 Mar; 34(3):745-56. PubMed ID: 22892311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta.
    Reynolds CH; Betts JC; Blackstock WP; Nebreda AR; Anderton BH
    J Neurochem; 2000 Apr; 74(4):1587-95. PubMed ID: 10737616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer's transgenic mice.
    Zeitlin R; Patel S; Burgess S; Arendash GW; Echeverria V
    Brain Res; 2011 Oct; 1417():127-36. PubMed ID: 21907331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling.
    Kickstein E; Krauss S; Thornhill P; Rutschow D; Zeller R; Sharkey J; Williamson R; Fuchs M; Köhler A; Glossmann H; Schneider R; Sutherland C; Schweiger S
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21830-5. PubMed ID: 21098287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorylation of microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase (JNK).
    Yoshida H; Hastie CJ; McLauchlan H; Cohen P; Goedert M
    J Neurochem; 2004 Jul; 90(2):352-8. PubMed ID: 15228592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis.
    Atzori C; Ghetti B; Piva R; Srinivasan AN; Zolo P; Delisle MB; Mirra SS; Migheli A
    J Neuropathol Exp Neurol; 2001 Dec; 60(12):1190-7. PubMed ID: 11764091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute anoxia induces tau dephosphorylation in rat brain slices and its possible underlying mechanisms.
    Liu R; Pei JJ; Wang XC; Zhou XW; Tian Q; Winblad B; Wang JZ
    J Neurochem; 2005 Sep; 94(5):1225-34. PubMed ID: 15992372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Protein Phosphatase-2A (PP2A) by I1PP2A Leads to Hyperphosphorylation of Tau, Neurodegeneration, and Cognitive Impairment in Rats.
    Wang X; Blanchard J; Tung YC; Grundke-Iqbal I; Iqbal K
    J Alzheimers Dis; 2015; 45(2):423-35. PubMed ID: 25589718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of protein phosphatase type 2A in monocytes from multiple trauma patients: a potential biomarker for sepsis.
    Yi HX; Zhang M; Wang JY; Luo RB; Jiang SY; Wang JA
    J Surg Res; 2014 Jun; 189(1):89-95. PubMed ID: 24679696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new paradigm for regulation of protein phosphatase 2A function via Src and Fyn kinase-mediated tyrosine phosphorylation.
    Sontag JM; Schuhmacher D; Taleski G; Jordan A; Khan S; Hoffman A; Gomez RJ; Mazalouskas MD; Hanks SK; Spiller BW; Sontag E; Wadzinski BE
    J Biol Chem; 2022 Aug; 298(8):102248. PubMed ID: 35820485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology.
    Liu R; Zhou XW; Tanila H; Bjorkdahl C; Wang JZ; Guan ZZ; Cao Y; Gustafsson JA; Winblad B; Pei JJ
    J Cell Mol Med; 2008; 12(1):241-57. PubMed ID: 18208556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein phosphatase 2A regulates apoptosis in intestinal epithelial cells.
    Ray RM; Bhattacharya S; Johnson LR
    J Biol Chem; 2005 Sep; 280(35):31091-100. PubMed ID: 15994315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of phosphotyrosyl phosphatase activator induces apoptosis via mitochondrial pathway and the attenuation by simultaneous tau hyperphosphorylation.
    Luo DJ; Feng Q; Wang ZH; Sun DS; Wang Q; Wang JZ; Liu GP
    J Neurochem; 2014 Sep; 130(6):816-25. PubMed ID: 24821282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteasome inhibition induces stress kinase dependent transport deficits--implications for Alzheimer's disease.
    Agholme L; Nath S; Domert J; Marcusson J; Kågedal K; Hallbeck M
    Mol Cell Neurosci; 2014 Jan; 58():29-39. PubMed ID: 24270002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-synuclein overexpression increases phospho-protein phosphatase 2A levels via formation of calmodulin/Src complex.
    Yang W; Wang X; Duan C; Lu L; Yang H
    Neurochem Int; 2013 Sep; 63(3):180-94. PubMed ID: 23796501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models.
    van Eersel J; Ke YD; Liu X; Delerue F; Kril JJ; Götz J; Ittner LM
    Proc Natl Acad Sci U S A; 2010 Aug; 107(31):13888-93. PubMed ID: 20643941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.